Article

High diffuse bone marrow uptake in 18 F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myeloma

2024-05-17

Abstract excerpt

<title>Abstract</title> To explore the biological implications of PET/CT findings in multiple myeloma (MM), we investigated the mutational characteristics relevant to PET/CT findings using targeted DNA sequencing. Fourteen newly diagnosed patients with MM who underwent 18F-fluorodeoxyglucose PET/CT at their initial diagnosis were included. For sequencing, a customized panel that covered 80 mutations...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 64d1bfd2-ee2a-51e3-9350-c5586871e3c7
DOI: 10.21203/rs.3.rs-4298024/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest

High diffuse bone marrow uptake in 18 F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myelomaDOI 10.21203/rs.3.rs-4298024/v1Read

High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myeloma.Semantic proximity Read

Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET StudySemantic proximity Read

A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integrationSemantic proximity Read

Functional transcriptomic landscape informs novel therapeutic strategies in multiple myelomaSemantic proximity Read

The Spatio-Temporal Evolution of Multiple Myeloma from Baseline to Relapse-Refractory StatesSemantic proximity Read

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.Semantic proximity Read

Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.Semantic proximity Read

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.Semantic proximity Read

<scp>ARNT</scp>/<scp>HIF</scp>‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myelomaSemantic proximity Read

The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple MyelomaSemantic proximity Read